Fertility-female
Conditions
Interventions
Group A
Group B
Sponsors
NWEZE SYLVESTER ONUEGBUNAM
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Pre-menopausal women between 18 and 42 years of age. Body mass index [BMI] greater or equals to 18 but less than or equals to 30 kg/m2 with a documented history of infertility. Women were in their early follicular phase and follicle-stimulating hormone level was less than or equals to 15 IU/L and early follicular phase of estradiol which was less than 80 pg./ml. A normal transvaginal ultrasound at screening and a negative pregnancy test during pituitary down-regulation Women who underwent ART treatment in Fertility and Reproduction Centers. Participants who gave consent to this study. Participants who had no obvious co-morbidity that was contraindicated in luteal support.
Exclusion criteria
Exclusion criteria: Women with more than 3 unsuccessful ART attempts or history of more than or equals to 3 miscarriages Evidence of cardiovascular, respiratory, urogenital, gastrointestinal/hepatic, hematologic/immunologic, head, ear, eye, nose, throat, dermatologic/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurologic/psychiatric disorders or other relevant diseases Women who had body mass index [BMI] less than 18 and greater than to 30 kg/m2 Women who had multiple gestation Women who were Allergic to progesterone (oral dydrogesterone [Duphaston] or micronised vaginal progesterone [Endometrin])
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of oral dydrogesterone and micronised vaginal progesterone in luteal phase support during assisted reproductive treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| the number of participants who despite adequate luteal phase support during assisted reproductive technology had uterine contraction, vaginal bleeding, additional interventions and miscarriages. | — |
Countries
Nigeria
Contacts
Public ContactIfeanyichukwu Ofor
Lecturer 1
Outcome results
None listed